Prof. Oyvind H. Lie presents trial findings on antithrombotic management following transcatheter aortic valve implantation (TAVI) at the ESC Congress 2026, evaluating optimal regimen strategies to balance ischemic risk reduction and bleeding complications.

Video: https://medicaldigest.org/scientific-contents/interview:acasa-tavi-antithrombotic-therapy-after-tavi

Prof. Henning Bundgaard presents landmark data from the REACT study at the ESC Congress 2026, mapping the prevalence of silent atherosclerosis across early to late adulthood and highlighting the role of early vascular imaging in primary prevention.

Video: https://medicaldigest.org/scientific-contents/interview:react-prevalence-silent-atherosclerosis-across-adult-life

Prof. Giuseppe Patti tracks the evolution of low-density lipoprotein cholesterol management in coronary artery disease at the ESC Congress 2026, drawing insights from the ARMYDA trials to the landmark AMUNDSEN study to optimize lipid-lowering strategies.

Video: https://medicaldigest.org/scientific-contents/interview:ldl-cholesterol-management-cad-armyda-amundsen

Prof. Ratika Parkash explores the critical role of managing comorbid conditions in atrial fibrillation at the ESC Congress 2026, emphasizing tailored risk factor modification and comprehensive multidisciplinary care.

Video: https://medicaldigest.org/scientific-contents/interview:comorbidities-require-special-attention-atrial-fibrillation

Prof. Helmut Puererfellner explores tailored approaches to atrial fibrillation management at the ESC Congress 2026, focusing on patient-specific symptom burdens, ablation vs. medical therapy, and targeted risk factor modification.

Video: https://medicaldigest.org/scientific-contents/interview:how-personalise-treatment-atrial-fibrillation

Prof. Kevin Damman outlines the new 2026 ESC Guidelines for managing cardiorenal syndrome at the ESC Congress 2026, focusing on early intervention, risk stratification, and integrated treatment approaches for co-existing CVD and CKD.

Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-cardiovascular-disease-and-chronic-kidney-disease

Prof. Michiel Rienstra discusses the practical implementation of the ESC Atrial Fibrillation Guidelines at the ESC Congress 2026, offering actionable strategies to streamline clinical workflows and optimize patient care.

Video: https://medicaldigest.org/scientific-contents/interview:practical-implementation-esc-atrial-fibrillation-guideline

Prof. Marianna Adamo outlines the updated 2026 ESC Guidelines for the Management of Heart Failure at the ESC Congress 2026, highlighting essential advances in diagnosis, early therapy initiation, and disease management.

Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-heart-failure

Prof. Elmir Omerovic presents key results from the SWITCH SWEDEHEART trial at the ESC Congress 2026, evaluating the safety and efficacy of switching from ticagrelor to prasugrel in patients with acute coronary syndromes.

Video: https://medicaldigest.org/scientific-contents/interview:switch-swedeheart-switching-ticagrelor-prasugrel-acs

Prof. Piotr Ponikowski discusses the critical gap between heart failure guidelines and real-world clinical practice, exploring the missing pieces needed for successful guideline-directed medical therapy (GDMT) implementation.

Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-key-takeaways-gdmt-implementation-report-esc-2026